Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis

Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is considered a novel anti-tumor target comparable to programmed cell death 1 ligand 1(PD-L1). However, little is known about Siglec-15. Our study aims to understand its expression signature, prognosis value, immune infiltration pattern,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Baihui, Zhang, Bailu, Wang, Xuezhou, Zeng, Ziqing, Huang, Ziqi, Zhang, Lin, Wei, Feng, Ren, Xiubao, Yang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480813/
https://www.ncbi.nlm.nih.gov/pubmed/32939323
http://dx.doi.org/10.1080/2162402X.2020.1807291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480813/
https://www.ncbi.nlm.nih.gov/pubmed/32939323
http://dx.doi.org/10.1080/2162402X.2020.1807291

Ejemplares similares